Diabetic patients taking statin drugs have a higher
risk of developing cataracts than people without diabetes
who are not on statins, according to a study in
emOptometry and Vision Science/em.sup1/sup
Researchers at the University of Waterloo, Ontario…
It is alleged by the US Securities and Exchange
Commission (SEC) that James Mazzo, president of
Abbott Medical Optics Inc. and long-time executive in
the ophthalmic industry, provided material nonpublic
information that led to insider trading.
Mr. Maz…
The risk of hip fractures was significantly reduced in patients who
underwent cataract surgery compared with patients diagnosed with a
cataract who did not undergo the procedure, according to a study in the
Journal of the American Medical Association.s…
ASCRS has formed an Integrated Ophthalmic-
Managed Eye Care Delivery (IOMED) Task Force to
investigate and recommend ways in which the organization
and its membership can advance an eye care
delivery model based on a synergistic collaboration between o…
Nationally, female physicians and surgeons earn
on average $12,194 less annually than men, according
to a study in the Journal of the American Medical
Association (JAMA) that investigated salary differences
between male and female physician researchers…
The AAO received a $1 million donation from
Charles Munnerlyn, PhD, and Judith G. Munnerlyn to
advance laser surgery education for ophthalmologists
around the world, according to a press release. This
gift, which is reportedly one of the largest indivi…
The apoptosis in lens epithelial cells increased in cataract patients with
diabetes mellitus with or without diabetic retinopathy (DR), according to
a study in the emJournal of Cataract and Refractive Surgery/em.sup1/sup
Participants were classified i…
The Victus Femtosecond Laser Platform (Bausch +
Lomb and Technolas Perfect Vision GmbH) received
510(k) clearance from the FDA for the creation of a
corneal flap in patients undergoing LASIK or other
treatments requiring initial lamellar resection of t…
Deep anterior lamellar keratoplasty using the big
bubble technique is a viable option in cases with
postinfectious keratitis and posttraumatic corneal
stromal scarring in eyes with a normal Descemet
membrane and endothelium, according to a study in
emC…
The American-European Congress of Ophthalmic
Surgery (ACOS) and Avedro, Inc., jointly announced
that the first patients have been treated in an ACOS
study of accelerated corneal collagen cross-linking
(CXL) utilizing Avedro’s KXL System. Patients wit…
Laser cataract surgery resulted in significantly better
predictability of IOL power calculation than conventional
phacoemulsification surgery, according to a
study in the emJournal of Refractive Surgery/em.sup1/sup
In this prospective study, 77 eyes (…
The iStent Trabecular Micro-Bypass (Glaukos
Corporation) has received approval from the FDA, a
decision that has the potential to change the way glaucoma
is treated in the United States. The iStent, which
is the first ab interno glaucoma implant to be …
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …
Significant changes in cyclotorsion and centroid shifts
occurred before surgery as well as intraoperatively with
both LASIK and PRK, according to a study in the emJournal
of Refractive Surgery/em.sup1/sup
The researchers measured intraoperative cyclor…
In the second of two phase 3 studies of bromfenac
ophthalmic solution (Prolensa; Ista Pharmaceuticals, Inc.)
for the treatment of pain and inflammation after cataract
surgery, the agent met the study’s primary and secondary
efficacy endpoints, accord…
James V. Mazzo, senior vice president of Abbott
Medical Optics Inc. (AMO), announced his plans to
retire from AMO at the end of the year. The news was
shared internally at AMO headquarters on May 17. The
company announced that Mr. Mazzo will be replace…
The first patients have been enrolled in the global
phase 2b clinical study BAYnovation, which will evaluate
the lead compound from NovaBay Pharmaceuticals, Inc.,
NVC-422, for the treatment of adenoviral conjunctivitis,
according to a company news rele…
Bausch + Lomb has named John Barr global president of
the company’s surgical business. Mr. Barr will oversee the
company’s full suite of ophthalmic surgical products, IOLs,
and delivery systems, according to a company news release.
Immediately pri…
A genetic factor called a repeating trinucleotide is a
strong predictor of an individual’s risk of developing
Fuchs corneal dystrophy, according to researchers at the
Mayo Clinic and University of Oregon.
The findings, which were presented at the 20…
Frank Ziemer, president and CEO of Ziemer
Ophthalmic Systems, cut a ribbon recently to formally open the new headquarters for Ziemer USA, Inc.
Ziemer USA is a wholly owned subsidiary of Ziemer
Ophthalmics and has occupied rented accommodations
in Alto…